Modulari-T

We teach your immune system to attack and cure cancer

Montreal, Canada

4 employees

Therapeutics

Seed · $500K

Website

About Modulari-T

Cell and gene therapy promises to one day cure any disease; Modulari-T’s Platform produces the tools to fulfill that promise.

Modulari-T has designed a new family of synthetic genes that can reprogram cells to better sense their environment and modify their behavior accordingly. This platform can be used to engineer immune cells to efficiently recognize and kill cancer cells, or to create stem cells that are able to regenerate any tissue.

Modulari-T looks to expand its technology to reach every area of cell therapy and become the platform of reference for cell engineering.

Company details

Team Size4

LocationMontreal, Canada

IndustryTherapeutics

Funding

Total raised

$500K

Last stage

Seed

Investors

Y Combinator

Pioneer Fund

Creative Destruction Lab

MMerck Digital Sciences Studio

BBoxOne Ventures

Founders

Stephanie Mok

Co-founder and COO at Modulari-T. PhD in chemical engineering. Technical background in synthetic biology, advanced 3D cell culture systems, and biomaterials in the context of the cellular cancer microenvironment. Fascinated by the innovations cell-based therapies, food products, and the scale up of their manufacturing. Gave the unconference talk "Lessons learned and mistakes made growing the world's hottest peppers".

David White

David is the CEO and cofounder of Modulari-T. His expertise spans multiple areas and he is driven by a passion for pushing the boundaries of technology. During his PhD he discovered how protein receptors form complex structures that allow them to alter cells’ behavior. He then took this knowledge and the novel technology that was developed to build Modulari-T. When he’s not thinking up a new way to engineer cells he can be spotted biking or running up a mountain.

David Cotnoir-White

Co-founder of Modulari-T Biosciences with expertise in cell and gene therapies, leading scientific strategy and platform innovation including the MARC platform.

Étienne Gagnon

Co-founder and Chief Scientific Officer at Modulari-T Bio, contributing to the development of next-generation cell and gene therapies.

What happens next.

No applications, no recruiter spam. Just the intro.

Confirm the fit

A few questions to make sure this role is the right shape for you. Two minutes.

I pitch you to the company

I write the intro, send it to the founder, and handle the back-and-forth.

A meeting lands on your calendar

If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.